Metraipolis › archive › dc_5abc7bffdc80

DNA methyltransferase inhibition is a therapeutic vulnerability in VHL-deficient renal cell carcinoma cells — Europe PMC PMID:41792232

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/41792232
DOI
10.1038/s12276-[numero omesso]-w
License (as archived)
solo-consultazione
Archived
2026-11-05T01:10:43.627Z
SHA-256 of the archived text
abcd086d74ce33d0916613e22cac86fa946878eaf6a58d26e0211075441d7033
Stable URL of this page
https://metraipolis.com/documento/dc_5abc7bffdc80

How to cite

DNA methyltransferase inhibition is a therapeutic vulnerability in VHL-deficient renal cell carcinoma cells — Europe PMC PMID:41792232 — Europe PMC (en), https://europepmc.org/article/MED/41792232 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_5abc7bffdc80 (Metraipolis archive dc_5abc7bffdc80, sha256 abcd086d74ce33d0916613e22cac86fa946878eaf6a58d26e0211075441d7033)
BibTeX
@misc{dc5abc7bffdc80,
  title = {DNA methyltransferase inhibition is a therapeutic vulnerability in VHL-deficient renal cell carcinoma cells — Europe PMC PMID:41792232},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/41792232},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_5abc7bffdc80; sha256 abcd086d74ce33d0916613e22cac86fa946878eaf6a58d26e0211075441d7033},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41792232. Agents can read the archived copy with the MCP tool read_document.